FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3124037800> ?p ?o ?g. }

• W3124037800 abstract "Abstract Cancer immunotherapies based mainly on the blockade of immune-checkpoint (IC) molecules by anti-IC antibodies offer new alternatives for treatment in oncological diseases. However, a considerable proportion of patients remain unresponsive to them. Hence, the development of novel clinical immunotherapeutic approaches and/or targets are crucial. In this context, targeting the immune-checkpoint HLA-G/ILT2/ILT4 has caused great interest since it is abnormally expressed in several malignancies generating a tolerogenic microenvironment. Here, we used CRISPR/Cas9 gene editing to block the HLA-G expression in two tumor cell lines expressing HLA-G, including a renal cell carcinoma (RCC7) and a choriocarcinoma (JEG-3). Different sgRNA/Cas9 plasmids targeting HLA-G exon 1 and 2 were transfected in both cell lines. Downregulation of HLA-G was reached to different degrees, including complete silencing. Most importantly, HLA-G – cells triggered a higher in vitro response of immune cells with respect to HLA-G + wild type cells. Altogether, we demonstrated for the first time the HLA-G downregulation through gene editing. We propose this approach as a first step to develop novel clinical immunotherapeutic approaches in cancer." @default.
• W3124037800 created "2021-02-01" @default.
• W3124037800 creator A5003372700 @default.
• W3124037800 creator A5005050970 @default.
• W3124037800 creator A5007864990 @default.
• W3124037800 creator A5023183070 @default.
• W3124037800 creator A5033410760 @default.
• W3124037800 creator A5041378929 @default.
• W3124037800 creator A5045011305 @default.
• W3124037800 creator A5046879793 @default.
• W3124037800 creator A5048600769 @default.
• W3124037800 creator A5048617242 @default.
• W3124037800 creator A5052029500 @default.
• W3124037800 creator A5054574258 @default.
• W3124037800 creator A5066817751 @default.
• W3124037800 creator A5072878164 @default.
• W3124037800 date "2021-01-22" @default.
• W3124037800 modified "2023-10-17" @default.
• W3124037800 title "HLA-G gene editing: a novel therapeutic alternative in cancer immunotherapy" @default.
• W3124037800 cites W1492588197 @default.
• W3124037800 cites W1506551612 @default.
• W3124037800 cites W1794357844 @default.
• W3124037800 cites W1977709885 @default.
• W3124037800 cites W2020090091 @default.
• W3124037800 cites W2029175700 @default.
• W3124037800 cites W2037690467 @default.
• W3124037800 cites W2044995847 @default.
• W3124037800 cites W2089889403 @default.
• W3124037800 cites W2142982199 @default.
• W3124037800 cites W2154854793 @default.
• W3124037800 cites W2158235544 @default.
• W3124037800 cites W2158829408 @default.
• W3124037800 cites W2167437201 @default.
• W3124037800 cites W2169794517 @default.
• W3124037800 cites W2335015241 @default.
• W3124037800 cites W2461468522 @default.
• W3124037800 cites W2508903105 @default.
• W3124037800 cites W2612299843 @default.
• W3124037800 cites W2728903533 @default.
• W3124037800 cites W2750487285 @default.
• W3124037800 cites W2782676239 @default.
• W3124037800 cites W2787448102 @default.
• W3124037800 cites W2795091386 @default.
• W3124037800 cites W2800311363 @default.
• W3124037800 cites W2807714507 @default.
• W3124037800 cites W2810896552 @default.
• W3124037800 cites W2883210621 @default.
• W3124037800 cites W2893124025 @default.
• W3124037800 cites W2893223637 @default.
• W3124037800 cites W2896809746 @default.
• W3124037800 cites W2900872097 @default.
• W3124037800 cites W2902620090 @default.
• W3124037800 cites W2905445906 @default.
• W3124037800 cites W2918690066 @default.
• W3124037800 cites W2971019999 @default.
• W3124037800 cites W3010889743 @default.
• W3124037800 cites W3015141182 @default.
• W3124037800 cites W3016213906 @default.
• W3124037800 cites W3038811719 @default.
• W3124037800 cites W608522650 @default.
• W3124037800 doi "https://doi.org/10.1101/2021.01.21.427294" @default.
• W3124037800 hasPublicationYear "2021" @default.
• W3124037800 type Work @default.
• W3124037800 sameAs 3124037800 @default.
• W3124037800 citedByCount "0" @default.
• W3124037800 crossrefType "posted-content" @default.
• W3124037800 hasAuthorship W3124037800A5003372700 @default.
• W3124037800 hasAuthorship W3124037800A5005050970 @default.
• W3124037800 hasAuthorship W3124037800A5007864990 @default.
• W3124037800 hasAuthorship W3124037800A5023183070 @default.
• W3124037800 hasAuthorship W3124037800A5033410760 @default.
• W3124037800 hasAuthorship W3124037800A5041378929 @default.
• W3124037800 hasAuthorship W3124037800A5045011305 @default.
• W3124037800 hasAuthorship W3124037800A5046879793 @default.
• W3124037800 hasAuthorship W3124037800A5048600769 @default.
• W3124037800 hasAuthorship W3124037800A5048617242 @default.
• W3124037800 hasAuthorship W3124037800A5052029500 @default.
• W3124037800 hasAuthorship W3124037800A5054574258 @default.
• W3124037800 hasAuthorship W3124037800A5066817751 @default.
• W3124037800 hasAuthorship W3124037800A5072878164 @default.
• W3124037800 hasBestOaLocation W31240378001 @default.
• W3124037800 hasConcept C121608353 @default.
• W3124037800 hasConcept C147483822 @default.
• W3124037800 hasConcept C151730666 @default.
• W3124037800 hasConcept C188280979 @default.
• W3124037800 hasConcept C203014093 @default.
• W3124037800 hasConcept C2777701055 @default.
• W3124037800 hasConcept C2779343474 @default.
• W3124037800 hasConcept C2780674031 @default.
• W3124037800 hasConcept C2780851360 @default.
• W3124037800 hasConcept C502942594 @default.
• W3124037800 hasConcept C54355233 @default.
• W3124037800 hasConcept C86803240 @default.
• W3124037800 hasConcept C8891405 @default.
• W3124037800 hasConceptScore W3124037800C121608353 @default.
• W3124037800 hasConceptScore W3124037800C147483822 @default.
• W3124037800 hasConceptScore W3124037800C151730666 @default.
• W3124037800 hasConceptScore W3124037800C188280979 @default.
• W3124037800 hasConceptScore W3124037800C203014093 @default.
• W3124037800 hasConceptScore W3124037800C2777701055 @default.

• next